Pharmaceuticals News and Research

RSS

Oral treatment of chronic hepatitis C

Valeant Pharmaceuticals today presented 24-week data from Phase 2 clinical trials of Viramidine, a nucleoside (guanosine) analog Valeant is developing in oral form for the treatment of chronic hepatitis C (HCV) in conjunction with a pegylated interferon.

17 Apr 2004

New and Generic Drug Approvals from FDA

Apidra, Diazepam Injection, Dopram, Fosamax and others

16 Apr 2004

Canadian Prime Minister Paul Martin pledges health care push

Any discussion of health care runs the risk of deteriorating into generalities. So let me be specific: We must reduce wait times. Canadians need to know, Wherever they live, how long it takes to get an MRI, how long it takes to see a doctor, to get needed hip surgery, and how quickly their child will be seen in the emergency ward.

16 Apr 2004

Delirium in ICU patients a predictor of mortality

Between 60 percent to 80 percent of these patients develop a brain dysfunction known as delirium, which according to a group of physicians at Vanderbilt Medical Center is an independent predictor of mortality.

16 Apr 2004

GlaxoSmithKline files asthma treatment drug for approval in Japan

GlaxoSmithKline plc announced today that it has filed SeretideTM DiskusTM for approval to the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of asthma in adults and children.

16 Apr 2004

Medicaid costs for a child's trip to an emergency room or clinic can be reduced annually by at least $198

Medicaid costs for a child's trip to an emergency room or clinic can be reduced annually by at least $198 per family when Head Start parents are provided with easy-to-understand health-care guidance, according to a first-of-its kind study by the UCLA/Johnson & Johnson Health Care Institute.

16 Apr 2004

How cutting-edge computer techniques can be used to develop drugs

Leading international experts will gather at the University of Bradford's Institute for Pharmaceutical Innovation (IPI) for a conference looking at how cutting-edge computer techniques can be used to develop drugs.

16 Apr 2004

Citrus soda culprit in patient’s medical mystery

It took a team of medical sleuths at Vanderbilt University Medical Center to get to the bottom of what was causing the 35-year-old to have abnormal blood chemistries during a post-transplant check up.

16 Apr 2004

Cancer could be inactivated by RNA library

CANCER RESEARCH UK and the Netherlands Cancer Institute have completed the first stage of a landmark initiative to systematically uncover the function of our genes, the charities announce today.

14 Apr 2004

New and Generic Drug Approvals from FDA

Colgate Total Toothpaste, Heparin Sodium in 5% Dextrose Injection, Heparin Sodium in 0.9% Sodium Chloride Injection and others

14 Apr 2004

Canadian health groups urge ban on exportation of pharmaceutical drugs from Canada to the U.S.

Canadian health groups today called on the Government of Canada to ban the exportation of pharmaceutical drugs from Canada to the U.S. The groups, who represent the interests of millions of Canadian patients, were in Washington to highlight their concerns with Internet pharmacies.

14 Apr 2004

Autism Associations shows CDC and FDA to be negligent

National Autism Association announced Tuesday that the Centers for Disease Control (CDC), Food and Drug Administration (FDA) and some pharmaceutical companies have become a target for investigation.

14 Apr 2004

EU ethical, social and legal aspects of human genetic testing

On 6 and 7 May 2004, the European Commission is inviting all interested parties to attend a European citizens’ and stakeholders’ conference to discuss the ethical, social and legal aspects of human genetic testing in research and healthcare applications.

14 Apr 2004

FDA approves advanced malignant melanoma drug

Maxim Pharmaceuticals today announced that its treatment protocol to provide its investigational drug Ceplene(TM), in combination with interleukin-2 (IL-2), for the treatment of patients with advanced malignant melanoma, has been approved by the U.S. Food and Drug Administration (FDA).

14 Apr 2004

Novartis to provide free medicines to low-income medicare recipients

Novartis Pharmaceuticals Corporation announced today that the company will work with Medicare-approved drug discount card sponsors to provide its products free of Novartis charges to low-income Medicare enrollees, after they have exhausted their $600 transitional assistance available from the government.

13 Apr 2004

New tool for study of carbohydrates could aid drug research

While many dieters are trying to cut carbs, a University of New Hampshire (UNH) biochemist has invented a way to capture them so scientists can more easily study their structure.

13 Apr 2004

Amount of adiponectin hormone lessens chance of heart attacks

Men with high levels of a Adiponectin hormone secreted by fat cells have a lesser chance of heart attacks, according to a new study that could lead to new ways to prevent and treat heart disease.

13 Apr 2004

Foreign drug repackager complies with FDA order

The Food and Drug Administration today announced the settlement of a court case against an Illinois firm involved last year in FDA's seizure of thousands of imported unapproved drugs, including those that were labeled in foreign languages and/or labeled as repacked.

13 Apr 2004

FDA makes moves to block foreign drug imports

The Food and Drug Administration today announced a new partnership with the Virginia Pharmacists Association to distribute consumer educational materials outlining the risks of purchasing medicines outside of FDA’s regulatory scope. Over the past month, FDA has co-sponsored agreements with state pharmacists associations in Illinois, California, Texas, Maryland, New York, and Nebraska, and the Agency anticipates that additional agreements will be signed in the weeks ahead.

13 Apr 2004

Coronary stent drives Johnson & Johnson to record profits

Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.

13 Apr 2004

Pharmaceuticals News and Research

Oral treatment of chronic hepatitis C

New and Generic Drug Approvals from FDA

Canadian Prime Minister Paul Martin pledges health care push

Delirium in ICU patients a predictor of mortality

GlaxoSmithKline files asthma treatment drug for approval in Japan

Medicaid costs for a child's trip to an emergency room or clinic can be reduced annually by at least $198

How cutting-edge computer techniques can be used to develop drugs

Citrus soda culprit in patient’s medical mystery

Cancer could be inactivated by RNA library

New and Generic Drug Approvals from FDA

Canadian health groups urge ban on exportation of pharmaceutical drugs from Canada to the U.S.

Autism Associations shows CDC and FDA to be negligent

EU ethical, social and legal aspects of human genetic testing

FDA approves advanced malignant melanoma drug

Novartis to provide free medicines to low-income medicare recipients

New tool for study of carbohydrates could aid drug research

Amount of adiponectin hormone lessens chance of heart attacks

Foreign drug repackager complies with FDA order

FDA makes moves to block foreign drug imports

Coronary stent drives Johnson & Johnson to record profits

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest Life Science News